Methylation of the p15INK4B gene in myelodysplastic syndrome: It can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation

British Journal of Haematology

Volumn 112, Issue 1, 2001, Pages 148-154

  Tien, Hwei Fang ^a   Tang, Jih Luh ^a   Tsay, Woei ^a   Liu, Ming Chi ^a   Lee, Fenn Yu ^a   Wang, Chiu Hwa ^a   Chen, Yao Chang ^a   Shen, Ming Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Methylation; Myelodysplastic syndrome; p15INK4B

Indexed keywords

PROTEIN P15;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; LEUKEMIA; MALE; MALIGNANT TRANSFORMATION; METHYLATION; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION;

ACUTE DISEASE; ANEMIA, REFRACTORY; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHI-SQUARE DISTRIBUTION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; DNA METHYLATION; ENZYME INHIBITORS; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROTEIN KINASE INHIBITORS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 0035134705     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02496.x     Document Type: Article

References (26)

1. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia
2. Proposals for the classification of the myelodysplastic syndromes
3. The myelodysplastic syndrome
4. Clonal karyotype abnormalities and clinical progress in myelodysplastic syndrome
5. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias
6. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
7. INK4B
8. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
9. INK4A characterize the major types of hematological malignancies
10. Role of the cyclin-dependent kinase inhibitors in the development of cancer
11. INK4B) in childhood acute lymphoblastic leukemia
12. Prognostic implication of morphology and karyotype in primary myelodysplastic syndromes
13. A cell cycle regulator potentially involved in genesis of many tumor types
14. Cytogenetic studies in 174 consecutive patients with preleukemia or myelodysplastic syndrome
15. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
16. Deletions of the cyclin-dependent Kinase-4 inhibitor gene in multiple human cancers
17. Loss of cyclin-dependent kinase 4-inhibitor (p16: MTS 1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies
18. INK4B gene in myelodysplastic syndromes is frequent and acquired during disease progression
19. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/DK4
20. Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome - A study on 68 Chinese patients in Taiwan
21. - T-cell acute lymphoblastic leukemia
22. INK4A) gene alternations in hematological malignancies
23. INK4B gene in myelodysplastic syndrome
24. Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
25. Refined chromosome analysis as an independent prognostic indicated in de novo myelodysplastic syndromes